(Q35111579)

6 August 2017

1 reference

title

Challenges in the treatment of depression with psychotic features (English)

1 reference

6 August 2017

1 reference

Anthony J. Rothschild

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706954

26 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706954

full work available at URL

26 December 2023

https://api.elsevier.com/content/article/PII:S000632230201747X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(02)01747-X

https://api.elsevier.com/content/article/PII:S000632230201747X?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(02)01747-X

26 December 2023

published in

Biological Psychiatry

1 reference

6 August 2017

53

1 reference

6 August 2017

680-690

1 reference

6 August 2017

8

1 reference

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Olanzapine in the treatment of depressive disorders with psychotic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Urinary free cortisol in psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Efficacy of amoxapine in psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Relapse in delusional depression: a retrospective study of the course of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The prognosis of depression in old age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Rapid reversal of psychotic depression using mifepristone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Cortisol activity and cognitive changes in psychotic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

An open label trial of C-1073 (mifepristone) for psychotic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional depression, family history, and DST response: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clozapine use in diffuse Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The importance of psychotic features to major depression: course and outcome during a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Affective Syndromes, Psychotic Features, and Prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Importance of psychotic features to long-term course in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The clinical and neuroendocrine features of psychotic depression.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Primary Unipolar Depression and the Prognostic Importance of Delusions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic features in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Demographic, Historical, and Symptomatic Features of the Nonmanic Psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Outcome at Discharge and Six Months in Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clozapine in the treatment of psychotic refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Treatment of psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Elevated plasma homovanillic acid in depressed females with melancholia and psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The dexamethasone suppression test in the clinical setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic depression: a separate entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic depressive disorder. A separate entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Imipramine (Tofranil) in depressive states: a controlled trial with inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Fluvoxamine alone in the treatment of delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clinical implications of imipramine plasma levels for depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional depression. A distinct clinical entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Recurrent psychotic depression. Evidence of diagnostic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The validity of major depression with psychotic features based on a community study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional Depressions: Natural History and Response to Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Candidate neuroanatomic substrates of psychosis in old-aged depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The Endocrine Effects of Long-Term Treatment with Mifepristone (RU 486)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Subtypes of depression. Family study perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The prognostic importance of delusions in depression: a 6-year prospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional depression: phenomenology and response to treatment. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Olanzapine in the treatment of psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Plasma catecholamine metabolites in subtypes of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Late-life delusional depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The prognosis of depression in old age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional unipolar depression: description and drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

DST studies in psychotic depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Lithium augmentation in psychotic depression refractory to combined drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional depression*Phenomenology, neuroendocrine function, and tricyclic antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Use of ECT for the inpatient treatment of recurrent major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Electroconvulsive therapy in delusional and non-delusional depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Distinguishing psychotic and non-psychotic melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic (delusional) depression: a meta-analysis of physical treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Effect of Clozapine on Psychotic Depression and Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Family history in delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The dexamethasone suppression test in psychotic versus non-psychotic endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Delusional depression. A one year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Depression, delusions, and suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Management of psychotic, treatment-resistant depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Olanzapine response in psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

How Long Should Patients With Psychotic Depression Stay on the Antipsychotic Medication?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Selective serotonin reuptake inhibitors and delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

The pharmacological treatment of delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Electroencephalographic sleep in psychotic depression. A valid subtype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Is delusional depression related to bipolar disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Electroconvulsive therapy in the treatment of depression: the impact on length of stay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Ketoconazole administration in hypercortisolemic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

An atypical responder to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Clinical predictors of acute response with quetiapine in psychotic mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

Neuropsychological deficits in psychotic versus nonpsychotic unipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901747-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders

57

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(02)01747-X

Relative Efficacy Rates for Therapies of Delusional Depression

26 December 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(02)01747-X

26 December 2023

Delusional depression

98

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(02)01747-X

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference